SHZ · 000513.SZ
Livzon Pharmaceutical Group Inc.
CN¥28.52+CN¥0.88 (+3.18%)
Livzon Pharmaceutical Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.65% below the high.
Loading market information…
SHZ · 000590.SZ · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Guhan Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.39% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Guhan Pharmaceutical Group Co., Ltd.’s forward annual dividend is CN¥0.20 per share, paid annual. The forward yield is 2.58% at the quoted price. Future payments can change.
Dividend payment history is currently unavailable.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Guhan Pharmaceutical Group Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Guhan Pharmaceutical Group Co., Ltd., along with its various subsidiaries, operates as a prominent Chinese pharmaceutical enterprise. The company focuses on the production and distribution of traditional Chinese medicine (TCM), conventional chemical pharmaceuticals, and health supplements within the domestic market. Its business activities are organized into specific segments, including the manufacturing and sale of traditional Chinese medicine, the manufacturing and sale of Western medicine, and a range of other operations. The company boasts a comprehensive product catalog featuring both prescription and over-the-counter (OTC) drugs. This selection includes tonics and health-boosting preparations, medications for cardiovascular and cerebrovascular conditions, nutritional products for children, cold and flu remedies, and detoxifying agents. Beyond its core manufacturing, Guhan Pharmaceutical is involved in a diverse array of additional services and ventures. These encompass health and nutrition advisory services, the cultivation of Chinese medicinal herbs, extensive medical research and experimental development, planning for cultural and artistic exchanges, general medical consultations, online sales, technology promotion, consulting agent services, outpatient care, and comprehensive pharmaceutical wholesale and retail operations. Founded in 1956, the company is headquartered in Hengyang, China. It was previously known as Tus-Pharmaceutical Group Co., Ltd., officially adopting its current name, Guhan Pharmaceutical Group Co., Ltd., in November 2025.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:28 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥28.52+CN¥0.88 (+3.18%)
Livzon Pharmaceutical Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.65% below the high.
CN¥12.95+CN¥0.23 (+1.81%)
Zhejiang Hisun Pharmaceutical Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.67% below the high.
¥3,821+¥47 (+1.25%)
Tsumura & Co.’s quoted price sits in the lower half of its reported 52-week range, 13.22% below the high.
CN¥15.04+CN¥0.54 (+3.72%)
Guobang Pharma Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.77% below the high.
CN¥4.34+CN¥0.01 (+0.23%)
Northeast Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.81% below the high.
CN¥9.77+CN¥0.08 (+0.83%)
Wanbangde Pharmaceutical Holding Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 73.04% below the high.
CN¥3.91-CN¥0.03 (-0.76%)
Hainan Haiyao Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 57.68% below the high.
CN¥8.70+CN¥0.15 (+1.75%)
Teyi Pharmaceutical Group Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 42.8% below the high.
